BackLixte Biotechnology Holdings Overview

Lixte Biotechnology Holdings Net Tangible Assets

Latest net tangible assets for LIXT: $9.2M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$9.18M

Peer average

Loading

Lixte Biotechnology Holdings Net Tangible Assets History

Loading

Lixte Biotechnology Holdings vs. peers: Net Tangible Assets Comparison

Loading

Lixte Biotechnology Holdings Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lixte Biotechnology Holdings (LIXT) FAQ

Lixte Biotechnology Holdings (LIXT) currently reports a net tangible assets of $9.2M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Lixte Biotechnology Holdings's net tangible assets history and peer comparisons.

Lixte Biotechnology Holdings's net tangible assets changed from $0 to $9.2M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lixte Biotechnology Holdings reported $9.2M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $9.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lixte Biotechnology Holdings, and consider following LIXT for alerts when major investors trade the stock.

Lixte Biotechnology Holdings is classified in the Healthcare sector. On net tangible assets, it currently shows $9.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LIXT with unrelated industries.